Research paper

View All
  • Ana Paula Beck da Silva Etges

    The Economic Impact of COVID-19 Treatment at a Hospital-level: Investment and Financial Registers of Brazilian Hospitals

    Get Access
  • Karen S. Yee

    Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review

    Get Access
  • Dingwei Dai

    Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population

    Get Access
  • Ehab L. Atallah

    Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective

    Get Access
  • Folashayo Adeniji

    Response to Letter to the Editor

    Get Access
  • Naomi van Hest

    Use of Minimal Residual Disease Status to Reduce Uncertainty in Estimating Long-term Survival Outcomes for Newly Diagnosed Multiple Myeloma Patients

    Get Access
  • Manjusha Hurry

    Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data

    Get Access
  • Gabriel Tremblay

    Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons

    Get Access
  • Onur Baser

    Use of Open Claims vs Closed Claims in Health Outcomes Research

    Get Access
  • Tia G. Sawhney

    QALYs: The Math Doesn’t Work

    Get Access
Your Feedback